Maleate

• Uses temporarily relieves: runny nose sneezing itchy, watery eyes due to hay fever itching of the nose or throat

Directions do not take more than 6 doses in any 24-hour period measure only with dosage cup provided keep dosage cup with product ml = milliliter age Dose adults and children 12 years and over 20 ml every 4 hours children 6 to under 12 years 10 ml every 4 hours children under 6 years do not use

Do not use to sedate a child or to make a child sleepy Ask a doctor before use if you have trouble urinating due to an enlarged prostate gland glaucoma a breathing problem such as emphysema, or chronic bronchitis. Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers When using this product do not use more than directed drowsiness may occur avoid alcoholic drinks alcohol, sedatives, and tranquilizers may increase drowsiness be careful when driving a motor vehicle or operating machinery excitability may occur, especially in children If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away at 1-800-222-1222.

• Dec 24, 1985NDANDA018998Bausch
• Nov 5, 1986NDANDA019463Bausch And Lomb Inc
• Nov 4, 1993NDANDA020330Bausch And Lomb Inc
• Jun 8, 1994NDANDA020226Alcon
• Jan 31, 1996NDANDA020485Kenvue Brands
• Apr 7, 1998NDANDA020869Thea Pharma
• Oct 21, 1998NDANDA020963Sandoz
• Dec 19, 2002NDANDA021441Haleon Us Holdings

1. 1Drug Ineffective10,0457.2%
2. 2Fatigue8,2655.9%
3. 3Nausea7,9515.7%
4. 4Dyspnoea6,5544.7%
5. 5Diarrhoea6,5304.7%
6. 6Headache6,4374.6%
7. 7Dizziness5,6044.0%
8. 8Off Label Use5,3033.8%
9. 9Pain5,1293.7%
10. 10Vomiting4,7263.4%
11. 11Asthenia4,1813.0%
12. 12Pneumonia3,8792.8%
13. 13Cough3,7562.7%
14. 14Fall3,6592.6%
15. 15Malaise3,5782.6%

The 10 most recently updated of 478 ClinicalTrials.gov registrations naming Maleate as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

• Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
  Recruiting · Phase 2 · Interventional · 2,900 enrolled · National Cancer Institute (NCI)
  NCT05564377updated 2026-06-12
• Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
  Recruiting · Phase 2 · Interventional · 70 enrolled · National Cancer Institute (NCI)
  NCT06126276updated 2026-06-11
• Acalabrutinib Maleate and Bortezomib for Patients With HLA Antibodies
  Not yet recruiting · Phase 3 · Interventional · 42 enrolled · The First Affiliated Hospital of Soochow University
  NCT07635511updated 2026-06-09
• Pyrotinib Plus Trastuzumab and Chemotherapy for HER2-Positive Early Breast Cancer
  Recruiting · Phase 2 · Interventional · 182 enrolled · Hebei Medical University Fourth Hospital
  NCT07635342updated 2026-06-09
• Fixed-dose Combination of 1000 mg Dipyrone Monohydrate + 60 mg Caffeine + 4 mg Chlorpheniramine Maleate in Improving Symptoms of the Common Cold and Flu in Adults
  Recruiting · Phase 3 · Interventional · 620 enrolled · Brainfarma Industria Química e Farmacêutica S/A
  NCT07626437updated 2026-06-04
• Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
  Active not recruiting · Phase 3 · Interventional · 579 enrolled · National Cancer Institute (NCI)
  NCT02446600updated 2026-06-03
• Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone
  Active not recruiting · Phase 2 · Interventional · 288 enrolled · National Cancer Institute (NCI)
  NCT03660826updated 2026-06-02
• A Study to Assess the Effectiveness of a Marketed Denture Adhesive in Real-World Setting
  Completed · Interventional · 375 enrolled · HALEON
  NCT07273149updated 2026-06-02
• Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents
  Active not recruiting · Phase 2 · Interventional · 120 enrolled · National Cancer Institute (NCI)
  NCT04739800updated 2026-05-29
• Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma
  Active not recruiting · Phase 1 · Phase 2 · Interventional · 117 enrolled · National Cancer Institute (NCI)
  NCT01064648updated 2026-05-29

Frequently asked questions

What is Maleate used for?

According to FDA labeling, Maleate carries indications including: Uses temporarily relieves: runny nose sneezing itchy, watery eyes due to hay fever itching of the nose or throat. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.